Subject: Bernadine Healy, Cardiologist, to Head NIH Date: Published: 9/10/90 (103 lines) Source: Wall Street Journal. Copyright Dow Jones & Co. Inc. Who's News: Health Secretary Picks Bernadine Healy, Cardiologist, to Head National Institutes ---- By Kenneth H. Bacon Staff Reporter of The Wall Street Journal WASHINGTON -- Health and Human Services Secretary Louis Sullivan has selected Bernadine Healy, a cardiologist, to become the director of the National Institutes of Health. In addition, HHS officials said that Dr. Sullivan is about to choose David Kessler, the medical director of the Albert Einstein College of Medicine in New York, as the next commissioner of the Food and Drug Administration. Dr. Kessler, a former aide to Sen. Orrin Hatch (R., Utah), is a member of an HHS advisory committee examining the FDA, which has lately suffered from problems ranging from inspector shortages to revelations of fraud in the generic-drug approval process. The FDA post has been vacant since last November, and the nomination would require Senate confirmation. HHS officials said that Dr. Sullivan already has asked the White House to clear the appointment of Dr. Healy, who is chairman of the Research Institute at the Cleveland Clinic Foundation. Dr. Healy won't be formally offered the National Institutes post until the White House approves, but HHS officials said she has told Dr. Sullivan she is interested in the directorship of the world's leading medical research organization. A member of Dr. Healy's office said she was on vacation and couldn't be reached for comment. The appointment of Dr. Healy would be a coup for Dr. Sullivan. Her prestige would help address recent complaints in Congress and elsewhere that the National Institutes has paid insufficient attention to diseases affecting women, to testing promising new therapies on women and to promoting women researchers. Dr. Healy, a former president of the American Heart Association, has spoken out publicly on the need to move more women into leadership positions in medical research and administration. The National Institutes post has been vacant since Aug. 1, 1989, when the Bush administration's anti-abortion politics forced Director James Wyngaarden to resign. Several prominent physicians, including Anthony Fauci, who heads the AIDS research program at the National Institutes, and William Danforth, the chancellor of Washington University in St. Louis and the brother of Sen. John Danforth (R., Mo.), have rejected the job. Scientists have said that the post's relatively low salary and limited authority, as well as fears that the administration's anti-abortion policies would limit some research initiatives, have made the National Institutes post difficult to fill. To address these concerns, Dr. Sullivan announced that the White House had assured him that "standards of scientific and administrative excellence and leadership," not politics, would prevail in the selection. He also has vowed to seek more authority and pay for the National Institutes director. Currently, the National Institutes director makes around $100,000 annually, about half what heads of medical school departments earn. Dr. Healy's appointment would show that the administration isn't imposing an ideological litmus test for the National Institutes post. HHS officials said Dr. Healy has opposed the administration's ban on the use of fetal tissue in research. The administration fears that if fetal-tissue transplants led to new treatments for such degenerative diseases as Alzheimer's and Parkinson's, pressure for abortions could rise. Dr. Healy has served as the president of the American Federation for Clinical Research, which has opposed the government's ban on fetal-tissue research. Dr. Healy has some Washington experience. She is a member of President Bush's Council of Advisers on Science and Technology, and she was deputy director of the White House Office of Science and Technology Policy from February 1984 through September 1985. At the Cleveland Clinic, which is headed by her husband, Floyd Loop, Dr. Healy has worked aggressively to boost the budget and prestige of the Research Institute. Research funding grew to $36 million last year from $8 million in 1985, with much of the money coming from the National Institutes. @ By contrast, the National Institutes budget is $7.6 billion this year. Yet the National Institutes faces a variety of problems -- funding hasn't kept up with research demands and many talented scientists are leaving for higher paying jobs elsewhere. In addition, the new National Institutes director will face a host of complex policy issues ranging from how to prevent research fraud to developing rules to sorting out the ethical and legal issues that arise as scientists learn how to analyze genes to detect disease and manipulate genes in an effort to cure or prevent disease. --- Timothy Noah contributed to this article. [This article is made available here by Dow Jones Co. for the personal and non-commercial use of callers to this bbs, in the hope that it will be of some help to those who are suffering from the disease and others who are seeking to help them.]